ReviewCancers2024
Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC.
Evangelia Bogatsa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it
ReviewCancers2024
Evangelia Bogatsa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.